The utility of transcriptome data for identifying molecular signatures that correlate with survival has been recently demonstrated, identifying a subgroup of ALS patients with poorer survival and differential expression of genes related to glial signalling.66,67 Here we identify BDNF expression as a clinical correlate of survival, highlighting the additional mechanistic insights afforded through our targeted approach. This evidence concerns the gene BDNF and amyotrophic lateral sclerosis.